Immediate inventory allocations for global contract testing laboratories, research facilities, and synthetic formulation plants. Full chromatographic tracing and analytical dossiers provided.
Methenolone Enanthate (Chemical Abstracts Service Registry Number 434-05-9) occupies a critical niche within global pharmaceutical intermediates, reference standard synthesis, and endocrine receptor bio-assays.
CAS 434-05-9, scientifically recognized as 17β-(heptanoyloxy)-1-methyl-5α-androst-1-en-3-one, has experienced sustained procurement volume increases across European, North American, and Asia-Pacific research supply chains. International demand is driven primarily by certified reference material (CRM) manufacturers, academic metabolic mapping units, and contract synthesis organizations studying steroid backbone modifications. As regulatory authorities tighten enforcement under ICH Q3A/B guidelines, procurement officers have systematically eliminated grey-market brokers in favor of audited, direct primary manufacturers.
The methenolone ester derivative exhibits a distinctive 1-methyl substitution coupled with an unsaturated 1-en bond on ring A, which effectively prevents aromatization into estrogenic metabolites during downstream scientific modeling. The enanthate ester linkage at C-17β modulates lipid solubility and kinetic hydrolysis rates. Maintaining stoichiometric precision during the esterification of the steroidal nucleus is paramount to preventing unreacted 17-hydroxy intermediates, which otherwise compromise analytical chromatographic profiles.
Global enterprises handling CAS 434-05-9 require extensive documentation trails complying with DEA (Title 21 CFR), EMA reference material standards, and regional chemical registration frameworks. Legitimate procurement channels prioritize suppliers who provide end-user declarations (EUD), import/export licensing support, verifiable HS codes (2937290000), and transparent logistics documentation ensuring frictionless customs clearance across 40+ countries.
China's centralized chemical engineering infrastructure in Hebei, Jiangsu, and Hubei provinces delivers unparalleled economies of scale, vertical precursor integration, and automated purification safety.
The manufacturing efficiency of Chinese chemical plants stems directly from domestic control over core phytosterol raw materials (such as androstenedione (4-AD) derived through microbial fermentation). By bypassing third-party precursor markups, modern synthesis workshops in Shijiazhuang and surrounding industrial clusters maintain complete raw material autonomy, mitigating supply shocks and offering global procurement partners stable forward pricing agreements even during volatile global market conditions.
Traditional batch reaction vessels are being replaced by automated continuous-flow tubular reactors for key oxidation and esterification steps. This technical transition eliminates thermal hot spots during the enanthic anhydride coupling stage, drastically cutting unreacted side products and achieving consistent purity yields exceeding 99.2% directly from the crude reaction mixture prior to primary crystallization.
Modern Chinese exporting plants operate in alignment with Western pharma quality systems. Every commercial shipment leaves the cleanroom facility with an individualized Certificate of Analysis (COA) cross-referenced by:
• High-Performance Liquid Chromatography (HPLC)
• Proton & Carbon Nuclear Magnetic Resonance (1H-NMR, 13C-NMR)
• High-Resolution Mass Spectrometry (HRMS)
• Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for heavy metals.
| Analytical Parameter | Commercial USP / EP Standard Target | Chinese Factory Batch Release (Exceeding Standards) | Primary Test Methodology |
|---|---|---|---|
| Chemical Identification | Conforms to Reference Standard IR Spectrum | 100% Structural Identity Confirmation | FTIR / 1H-NMR Spectroscopy |
| HPLC Assay (Dry Basis) | 97.0% – 102.0% | 99.35% – 99.80% | Reverse-Phase HPLC (UV @ 242 nm) |
| Individual Impurity | ≤ 1.0% | ≤ 0.20% (Typical < 0.08%) | Gradient HPLC Impurity Profiling |
| Loss on Drying (LOD) | ≤ 0.5% | ≤ 0.22% | Vacuum Desiccation @ 60°C |
| Residue on Ignition | ≤ 0.1% | ≤ 0.03% | Sulfated Ashing Protocol |
| Residual Solvents | Complies with ICH Q3C Class 2/3 limits | Below Detectable Quantitation Limit (BQL) | Headspace Gas Chromatography (GC-MS) |
| Heavy Metal Limits | ≤ 20 ppm total | ≤ 5 ppm combined (Pb, As, Cd, Hg) | ICP-MS Quantitative Digestion |
Understanding how downstream institutions deploy CAS 434-05-9 informs sourcing tolerances, packaging configurations, and crystallization sizing parameters.
In life science academia and pharmaceutical R&D laboratories, Methenolone Enanthate serves as a benchmark calibration agent for evaluating selective androgen receptor binding affinity (AR Kd). Researchers study the molecular mechanics of the non-aromatizable C1-C2 double bond to understand selective tissue response profiles and satellite cell activation pathways without estrogenic pathway interference.
Certified toxicology testing laboratories, anti-doping forensic facilities (WADA-accredited hubs), and environmental monitoring agencies utilize ultra-pure CAS 434-05-9 powder to establish baseline calibration curves for gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) metabolite identification in complex biological matrices.
Formulation scientists explore advanced non-aqueous solvent systems, evaluating the dissolution thermodynamics of CAS 434-05-9 in carrier media including ethyl oleate, medium-chain triglycerides (MCT), sesame oil, and benzyl alcohol / benzyl benzoate preservation matrices. Precise micronization and polymorphic consistency guarantee optimal kinetic stability without premature recrystallization.
The esterified 17β tail imparts notable ambient stability relative to unesterified steroid bases. Real-time stress testing demonstrates that when stored between 2°C and 8°C in amber, vacuum-sealed nitrogen-flushed vessels, Methenolone Enanthate powder exhibits a degradation rate of less than 0.05% annually over 36 consecutive months.
Ensuring total integrity from phytosterol fermentation through high-vacuum fractional crystallization and sterile packaging.
4-Androstenedione and phytosterol batches validated by NMR for stereochemical configuration and zero heavy-metal carryover.
Precise C-1 catalytic methylation and dehydrogenation creating the stable 1-methyl-5α-androst-1-en ring structure.
Esterification with enanthic acid in anhydrous solvents under temperature monitoring to ensure complete C-17β ester bonding.
Dual-solvent fractional crystallization removing trace reaction residues, followed by cleanroom vacuum drying.
HPLC validation (≥99.0%), double-barrier anti-static foil sealing under argon flush, and cold-chain dispatch staging.
How automated quality systems, green enzymatic chemistry, and strict vendor pre-qualification are transforming steroid intermediate procurement.
Traditional multi-step chemical reductions utilizing metal hydrides generate hazardous wastes and micro-contaminants. The industry trend spearheaded by leading Chinese synthesis clusters involves engineered biotransformation enzymes. Microbial selective dehydrogenation significantly reduces carbon emissions and guarantees stereospecific 5α hydrogen orientation without diastereomer contamination.
Global corporate buyers evaluate suppliers using stringent qualification matrices:
• Chromatographic Raw Data: Demanding full integration logs and baseline drift data, not mere numerical percentages.
• Chiral Integrity: Proving no racemization at chiral centers via optical rotation and chiral stationary phases.
• Endotoxin & Bioburden Limits: Routine LAL testing for bulk powder intended for sterile fill-finish operations.
• Supply Stability Guarantee: Minimum rolling warehouse inventories of 250kg–1,000kg ready for immediate dispatch.
To eliminate document falsification in the bulk chemical export market, tier-one manufacturers provide cryptographically signed Certificates of Analysis. Buyers can scan tamper-evident QR codes on outer pharmaceutical drums to instantly pull raw instrument spectra directly from laboratory analytical servers.
Direct answers to the most common queries raised by international pharmaceutical chemical purchasers and testing laboratories.
Full catalog availability for institutional research programs, analytical assay calibration, and ongoing clinical peptide/small-molecule synthesis.